Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
|
MARTEK BIOSCIENCES CORP (MATK)
|
Add to portfolio |
|
|
|
| Price: |
$31.47
| | Metrics |
| OS: |
33.5
|
M
| |
4
|
% ROE
|
| Market cap: |
$1.05
|
B
| |
15
|
% ROIC
|
|
Net cash:
|
$61.6
|
M
| |
$1.84
|
per share
|
|
EV:
|
$993
|
M
| | | |
| | | | | |
| TTM Valuation | | | |
|
EBITDA
|
$121
|
M
| |
8.2
|
x EV/EBITDA
|
|
EBIT
|
$85.8
|
M
| |
11.6
|
x EV/EBIT
|
| EPS |
$0.17
| |
184.5
|
x P/E
|
|
|
| |
|
|
|
Recent News + Filings (All items)
|
Revenue Mix by Segment
|
Financial Summary (All financials)
| In millions, except per share items | Oct-31-10 | Oct-31-09 | Oct-31-08 | Oct-31-07 | Oct-31-06 | Oct-31-05 | Oct-31-04 | Oct-31-03 |
| Revenues | 450.0 | 345.2 | 352.4 | 306.8 | 270.7 | 217.9 | 184.5 | 114.7 |
| Revenue growth | 30.4% | -2.0% | 14.8% | 13.4% | 24.2% | 18.1% | 60.8% | 149.1% |
| Cost of goods sold | 233.3 | 196.6 | 206.8 | 193.3 | 173.3 | 133.4 | 115.0 | 66.3 |
| Gross profit | 216.8 | 148.6 | 145.5 | 113.5 | 97.4 | 84.5 | 69.5 | 48.4 |
| Gross margin | 48.2% | 43.0% | 41.3% | 37.0% | 36.0% | 38.8% | 37.7% | 42.2% |
| Selling, general and administrative | | | | 44.9 | 39.6 | 32.0 | 25.8 | 16.3 |
| Sales and marketing | 14.3 | 1.9 | 2.7 | | | | | |
| Research and development | 33.6 | 27.4 | 26.2 | 24.9 | 24.0 | 19.4 | 18.6 | 13.2 |
| General and administrative | 71.2 | 48.1 | 51.4 | | | | | |
| EBITA | 96.3 | 70.0 | 63.6 | 42.2 | 32.6 | 25.4 | 21.1 | 14.8 |
| EBITA margin | 21.4% | 20.3% | 18.1% | 13.7% | 12.0% | 11.7% | 11.4% | 12.9% |
| Amortization of intangibles | 10.5 | 6.4 | 7.4 | 6.6 | 2.8 | 2.5 | | |
| EBIT | 85.8 | 63.6 | 56.2 | 35.6 | 29.8 | 22.9 | 21.1 | 14.8 |
| EBIT margin | 19.1% | 18.4% | 15.9% | 11.6% | 11.0% | 10.5% | 11.4% | 12.9% |
| Pre-tax income | 47.3 | 64.0 | 57.3 | 33.7 | 23.5 | 24.1 | 21.9 | 16.0 |
| Income taxes | 19.4 | 23.5 | 19.7 | 1.7 | 8.6 | 8.8 | -25.2 | 0.0 |
| Tax rate | 41.0% | 36.6% | 34.3% | 4.9% | 36.5% | 36.5% | | 0.0% |
| Net income | 27.9 | 40.6 | 37.7 | 32.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Net margin | 6.2% | 11.8% | 10.7% | 10.4% | 0.0% | 0.0% | 0.0% | 0.0% |
| |
| Diluted EPS | $0.83 | $1.22 | $1.13 | $0.98 | $0.00 | $0.00 | $0.00 | $0.00 |
| Shares outstanding (diluted) | 33.6 | 33.4 | 33.3 | 32.6 | 32.3 | 32.0 | 30.4 | 27.4 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|
|